CT52923 is a selective, orally active platelet-derived growth factor receptor (PDGFR) antagonist. CT52923 also is an ATP-competitive inhibitor. CT52923 can be used for the research variety of pathological diseases, including atherosclerosis, glomerulonephritis, liver cirrhosis, pulmonary fibrosis, and cancer[1].
Molecular Weight:
467.54
Purity:
98.58
CAS Number:
[205256-55-9]
Formula:
C23H25N5O4S
Target:
PDGFR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted